SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001445305-14-003744
Filing Date
2014-08-18
Accepted
2014-08-18 17:27:58
Documents
5
Period of Report
2014-08-18
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K form8-kbioservetransaction.htm 8-K 40787
2 EXHIBIT a41mainindianagreement.htm EX-4.1 657916
3 EXHIBIT a42stockpurchaseagreement.htm EX-4.2 108174
4 EXHIBIT a991pressreleasebioserve.htm EX-99.1 17660
5 pressreleaseimage1.jpg GRAPHIC 8899
  Complete submission text file 0001445305-14-003744.txt   838181
Mailing Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070
Business Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 201.528.9200
CANCER GENETICS, INC (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35817 | Film No.: 141050003
SIC: 8071 Services-Medical Laboratories